Smith+Nephew announces strong performance results for joint replacement technology

Global medical technology company Smith+Nephew’s OXINIUM technology has shown strong performance measures in hip and knee arthroplasties.

Advertisement

OXINIUM is made with zirconium alloy that transforms into ceramicised metal through oxidation for enhanced performance, according to an Aug. 30 news release.

Using four national and regional joint registries with more than 2 million procedures over the past 20 years, the company found that its joint replacement technology showed the lowest risk of revision at 10 years for hip arthroplasties and high survivorship in total knee arthroplasty.

Smooth+Nephew also reported that its OXINIUM technology is associated with increased savings and lower readmission rates.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.